Advanced Medicine Partners manufactures viral vectors for gene and cell therapies using a proprietary adeno-associated virus (AAV) process that minimizes impurities and achieves over 95% functional full capsids. This technology provides reliable and scalable solutions for the production of therapeutics, meeting the rigorous demands of research and clinical applications in biotechnology.
Funding
$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The production of viral vectors for gene and cell therapies faces challenges in minimizing impurities and achieving high ratios of functional full capsids, which are crucial for therapeutic efficacy and regulatory compliance. Traditional contract development and manufacturing organizations (CDMOs) may struggle to consistently deliver the required purity and capsid ratios.
Solution
Advanced Medicine Partners (AMP) is a CDMO specializing in viral vector manufacturing for gene and cell therapies, utilizing a proprietary adeno-associated virus (AAV) process. AMP's platform is designed to minimize impurities and consistently generate functional full capsid ratios exceeding 95%. This AAV manufacturing process provides reliable and scalable solutions for producing advanced therapy products that meet stringent regulatory expectations. AMP offers comprehensive services from process development and analytical development to GMP manufacturing, supporting projects from concept to commercialization.
Target Audience
AMP primarily serves biotechnology companies developing gene and cell therapies, requiring reliable and scalable viral vector manufacturing with high purity and functional capsid ratios.
Features
- Proprietary AAV manufacturing process that minimizes impurities
- Consistently generates >95% functional full capsids
- Platform upstream process for AAV with multiple wildtype AAV serotypes and engineered capsids
- Animal origin free (GMP-ready materials)
- Chromatography steps with all modalities (Affinity, IEX, size exclusion, etc.)
- State-of-the-art analytical laboratories and equipment designed to meet cGMP standards
- CMC strategy development, IND/IMPD CMC documentation preparation and agency support
- cGMP manufacturing facility with flexibility for clinical and commercial production across modalities